The group’s initial objective was to enhance the therapy of ovarian carcinoma. The AGO Study Group has been established in 1993 as a non-profit organisation under the original name ‘AGO Studiengruppe Ovarialkarzinom (AGO-OVAR)’.
Angaben gemäß § 5 TMG:
AGO Research GmbH
Managing Director: Stefanie Barth
Registered Seat: Kaiser-Friedrich-Ring 71, 65185 Wiesbaden
Fon: +49 611 880467-0
Fax: +49 611 880467-67
County Court Wiesbaden HRB 24129
UVAT identification number DE 264466146
Haftung für Inhalte
Interested parties may gather information on AGO Research GmbH and its activities on these pages. All prices, data and further information concerning AGO Research GmbH as well as the events staged there are subject to ongoing updates and amendments. The information provided is constantly updated. However, AGO Research GmbH is not responsible for the correctness and completeness of the information. AGO Research GmbH has inspected all linked pages with the utmost, reasonable diligence. It states explicitly that it is not responsible for the content of these pages, disclaims any liability and shall not be held accountable for the content of these pages.
Use of contact information
The use of the contact data published in the imprint or comparable information such as postal addresses, telephone and fax numbers as well as email addresses by third parties for the transmission of not expressly requested information is not permitted. Legal action against the senders of so-called spam mails in case of violations of this prohibition are expressly reserved.
Layout, texts, images and graphics on this page are protected by law. This applies in particular to brand and patent rights, but also to all other forms of intellectual property rights. Reproduction and / or distribution of individual contents of these pages in whole or in part and / or of complete pages are strictly forbidden. Any violation will be prosecuted to the fullest extent of the civil and / or criminal law.